Ligand profile
AWH
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03545 — Cysteine synthase B
Identifiers
Database identifiers and provenance.
- Ligand ID
AWH- PDB
3zei- UniProt (similar protein)
P9WP55- Target protein
- KP13_03545
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 116.5
- −1 ≤ LogP ≤ 5 3.08
- MW ≤ 500 Da 412.4
- LogP ≤ 5 3.08
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 116.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN\1C(=O)/C(=C/c2ccccc2OCC(=O)O)/S/C1=N\c3cccc(c3)C(=O)OCN\1C(=O)/C(=C/c2ccccc2OCC(=O)O)/S/C1=N\c3cccc(c3)C(=O)O
InChI=1S/C20H16N2O6S/c1-22-18(25)16(10-12-5-2-3-8-15(12)28-11-17(23)24)29-20(22)21-14-7-4-6-13(9-14)19(26)27/h2-10H,11H2,1H3,(H,23,24)(H,26,27)/b16-10-,21-20-InChI=1S/C20H16N2O6S/c1-22-18(25)16(10-12-5-2-3-8-15(12)28-11-17(23)24)29-20(22)21-14-7-4-6-13(9-14)19(26)27/h2-10H,11H2,1H3,(H,23,24)(H,26,27)/b16-10-,21-20-
ZRWLYRDALGQUID-PTWQKYQPSA-NZRWLYRDALGQUID-PTWQKYQPSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00291
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand AWH →
- PDB RCSB structure 3zei →
- UniProt UniProt P9WP55 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “AWH”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03545.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).